Parkinson's Disease: Genetics, Symptoms, and Treatment
This paper provides a comprehensive overview of Parkinson's disease, the second most prevalent neurological disorder worldwide. It examines the neurological basis of the disease, including the degeneration of dopamine-producing nerve cells in the substantia nigra and the resulting motor and cognitive symptoms. The paper discusses both sporadic and hereditary forms of the disease, detailing autosomal dominant and autosomal recessive inheritance patterns involving genes such as LRRK2, SNCA, PARK2, PARK7, and PINK1. It also covers diagnostic approaches, current treatment options including medication, physical therapy, and deep brain stimulation, and addresses the ethical controversy surrounding stem cell transplantation as a potential cure.
- Introduction to Parkinson's Disease: Prevalence, age of onset, and global impact
- Neurological Symptoms and Progression: Dopamine loss, tremors, and cognitive decline
- Genetic Inheritance Patterns: Dominant and recessive gene mutations involved
- Diagnosis and Family History: Diagnostic methods and role of family history
- Current Treatment Options: Medications, physical therapy, and brain stimulation
- Ethical Implications of Stem Cell Research: Moral debate over stem cell transplantation as cure
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper builds logically from basic neuroscience to genetics to treatment, giving readers a coherent conceptual progression through a complex medical topic.
- It integrates specific gene names (LRRK2, SNCA, PARK2, PARK7, PINK1) and chromosomal locations, demonstrating engagement with primary scientific literature rather than surface-level description.
- The concluding ethical discussion elevates the paper beyond a simple disease summary, connecting biomedical facts to real-world moral debate around stem cell research.
Key academic technique demonstrated
The paper effectively uses the cause-and-effect structure throughout: it explains the biological mechanism (dopamine depletion in the substantia nigra), traces the consequence (motor and cognitive symptoms), links those to genetic causes (inheritance patterns and specific gene mutations), and then follows the chain through to treatment limitations and ethical dilemmas. This layered causal reasoning gives the paper analytical depth beyond mere description.
Structure breakdown
The paper contains six functional sections: an epidemiological introduction; a detailed look at motor and non-motor symptoms; a genetics section covering inheritance modes and specific gene loci illustrated by Punnett square analysis; a diagnostic section emphasizing the role of family history; a treatment section covering pharmacological, physical, and surgical options; and a closing section on the ethics of stem cell use. Each section is approximately one paragraph in the source, making this a tightly organized undergraduate-level essay.
Introduction to Parkinson's Disease
Parkinson's disease is a neurological disorder that has become the subject of much research in recent years. This disease affects more than four million individuals around the world, making it the second most prevalent neurological disorder (National Institute of Health, 2013). The United States alone records about 60,000 new diagnoses every year. Parkinson's disease can affect an individual of any age; however, the form most familiar to the general public is late-onset Parkinson's disease, which encompasses those older than 55 years. Young-onset, or early-onset, Parkinson's disease affects individuals before the age of 50, while juvenile-onset Parkinson's disease affects those under the age of 20 (NHGRI, 2011). Regardless of the age at which the disease first appears, its devastating effects are the same.
References
EuroStemCell. (2012). Parkinson's disease: How could stem cells help? Eurostemcell.org. Retrieved 20 April 2013 from http://www.eurostemcell.org/factsheet/parkinson%E2%80%99s-disease-how-could-stem-cells-help
National Institute of Health. (2013). Parkinson disease. National Library of Medicine. Retrieved 20 April 2013 from http://ghr.nlm.nih.gov/condition/parkinson-disease
NHGRI. (2011). Learning about Parkinson's disease. National Human Genome Research Institute. Retrieved 20 April 2013 from http://www.genome.gov/10001217
Talan, J. (2012). Parkinson's disease. The New York Times. Retrieved 20 April 2013 from http://health.nytimes.com/health/guides/disease/parkinsons-disease/overview.html#Exams-and-Tests
Create your account
Always verify citation format against your institution’s current style guide requirements.